MALIGNANT NEOPLASM OF PLEURA

This adverse event was reported 123 times

These drugs are most commonly taken by patients reporting MALIGNANT NEOPLASM OF PLEURA:

# Drug Count
0 DOCETAXEL 15
1 DOCETAXEL ANHYDROUS 15
2 CARBOPLATIN 12
3 LETROZOLE 11
4 AFATINIB 10
5 BEVACIZUMAB 10
6 CYCLOPHOSPHAMIDE 10
7 CYCLOPHOSPHAMIDE FOR INJECTION 10
8 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 10
9 FULVESTRANT 9
See all common drugs associated with MALIGNANT NEOPLASM OF PLEURA

MALIGNANT NEOPLASM OF PLEURA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 L DOPA 2 0.0075
1 DACOMITINIB 3 0.0040
2 AFATINIB 10 0.0015
3 INAVOLISIB 1 0.0015
4 DACARBAZINE 4 0.0005
5 GRANULOCYTE COLONY STIMULATING FACTOR 1 0.0005
6 BRINZOLAMIDE 3 0.0003
7 ERLOTINIB HYDROCHLORIDE 4 0.0003
8 GADODIAMIDE 1 0.0003
9 VALSARTAN AND HYDROCHLOROTHIAZIDE 4 0.0003
See all drugs enriched for association with MALIGNANT NEOPLASM OF PLEURA